Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)
CUSIP: 869367102
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 84,733,230
- Total 13F shares
- 9,707,399
- Share change
- -491,657
- Total reported value
- $87,234,000
- Price per share
- $9.02
- Number of holders
- 41
- Value change
- -$10,616,486
- Number of buys
- 28
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SV Health Investors, LLC |
13F
|
Company |
2.2%
|
1,824,542
|
$27,368,000 | — | 30 Sep 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
1,748,421
|
$26,226,000 | — | 30 Sep 2018 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,244,895
|
$18,134,000 | — | 30 Sep 2018 | |
| Camber Capital Management LP |
13F
|
Company |
0.71%
|
600,000
|
$9,000,000 | — | 30 Sep 2018 | |
| COWEN INC. |
13F
|
Company |
0.49%
|
417,317
|
$6,260,000 | — | 30 Sep 2018 | |
| FMR LLC |
13F
|
Company |
0.47%
|
400,000
|
$6,000,000 | — | 30 Sep 2018 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
358,278
|
$5,374,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.4%
|
339,900
|
$5,098,000 | — | 30 Sep 2018 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.32%
|
275,000
|
$4,125,000 | — | 30 Sep 2018 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.3%
|
250,000
|
$3,750,000 | — | 30 Sep 2018 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.27%
|
232,539
|
$3,488,000 | — | 30 Sep 2018 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.27%
|
231,613
|
$3,474,000 | — | 30 Sep 2018 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
150,000
|
$2,250,000 | — | 30 Sep 2018 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.18%
|
150,000
|
$2,250,000 | — | 30 Sep 2018 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.17%
|
146,653
|
$1,686,000 | — | 30 Sep 2018 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.13%
|
111,483
|
$1,672,000 | — | 30 Sep 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
100,050
|
$1,501,000 | — | 30 Sep 2018 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.12%
|
100,000
|
$1,500,000 | — | 30 Sep 2018 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.09%
|
79,856
|
$1,201,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
76,662
|
$1,150,000 | — | 30 Sep 2018 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.08%
|
70,000
|
$1,050,000 | — | 30 Sep 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
47,645
|
$715,000 | — | 30 Sep 2018 | |
| DC Investments Management, LLC |
13F
|
Company |
0.05%
|
39,474
|
$592,000 | — | 30 Sep 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
28,300
|
$425,000 | — | 30 Sep 2018 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.03%
|
27,494
|
$412,000 | — | 30 Sep 2018 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.03%
|
25,000
|
$375,000 | — | 30 Sep 2018 | |
| Walleye Trading LLC |
13F
|
Company |
0.03%
|
21,263
|
$319,000 | — | 30 Sep 2018 | |
| Walleye Capital LLC |
13F
|
Company |
0.02%
|
13,395
|
$201,000 | — | 30 Sep 2018 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.01%
|
11,000
|
$165,000 | — | 30 Sep 2018 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
6,000
|
$90,000 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,248
|
$19,000 | — | 30 Sep 2018 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
500
|
$8,000 | — | 30 Sep 2018 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q4 2018
As of 31 Dec 2018,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,707,399 shares.
The largest 10 holders included
SV Health Investors, LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Samsara BioCapital, LLC, Camber Capital Management LP, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., FMR LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and Sio Capital Management, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
32
Q4 2018 holders
41
Holder diff
9
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.